Coya Therapeutics Successfully Engineers Regulatory T Cell (Treg) Derived Exosomes with CTLA-4 Protein to Selectively Target Immune Cells with Potential to Deliver Targeted Therapies Across Multiple Diseases - Allele Capital

https://ir.coyatherapeutics.com/news/news-details/2023/Coya-Therapeutics-Successfully-Engineers-Regulatory-T-Cell-Treg-Derived-Exosomes-with-CTLA-4-Protein-to-Selectively-Target-Immune-Cells-with-Potential-to-Deliver-Targeted-Therapies-Across-Multiple-Diseases/default.aspx